Azymus Therapeutics, an emerging pharmaceutical company, is advancing 10-years of nano-therapeutic research supported by its flagship AZ Platform. The company is studying applications of next-generation therapies in neurodegenerative diseases and chemo-resistant cancers. Azymus is partnering with universities, researchers, pharmaceutical companies, and investors to advance its treatments. “Azymus Therapeutics is developing solutions for diseases that currently lack effective treatments...